Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Optimizing therapy early in multiple sclerosis: An evidence-based view.
A case of acute combined central and peripheral demyelination.
From the Cajal alumni Achúcarro and Río-Hortega to the rediscovery of never-resting microglia.
Benefits, safety, and prescription of exercise in persons with multiple sclerosis.
Trial and error in clinical studies: lessons from ATAMS.
Sphingosine 1-phosphate receptor 1 agonists: a patent review (2013-2015).
S1P and the birth of platelets.
A single-group pilot feasibility study of cognitive behavioural therapy in people with multiple sclerosis with depressive symptoms.
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.
Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
Vitamin D as a clinical biomarker in multiple sclerosis.
A questionnaire survey comparing the educational priorities of patients and medical students in the management of multiple sclerosis.
Unmet Needs of Patients Feeling Severely Affected by Multiple Sclerosis in Germany: A Qualitative Study.
Knee muscle strength in multiple sclerosis: relationship with gait characteristics.
Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target.
Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosis.
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
Anti-interleukin-2 receptor alpha for multiple sclerosis?
A single session of 1 mA anodal tDCS-supported motor training does not improve motor performance in patients with multiple sclerosis.
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.
Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis.
Biochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids.
Pages
« first
‹ previous
…
343
344
345
346
347
348
349
350
351
…
next ›
last »